139 related articles for article (PubMed ID: 20340055)
1. Serum interleukine-6 concentration, but not interleukine-18, is associated with head and neck squamous cell carcinoma progression.
Mojtahedi Z; Khademi B; Hashemi SB; Abtahi SM; Ghasemi MA; Fattahi MJ; Ghaderi A
Pathol Oncol Res; 2011 Mar; 17(1):7-10. PubMed ID: 20340055
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma.
Riedel F; Zaiss I; Herzog D; Götte K; Naim R; Hörmann K
Anticancer Res; 2005; 25(4):2761-5. PubMed ID: 16080523
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of interleukins 4 and 10 in head and neck squamous cell carcinoma.
Mojtahedi Z; Khademi B; Yehya A; Talebi A; Fattahi MJ; Ghaderi A
J Laryngol Otol; 2012 Feb; 126(2):175-9. PubMed ID: 21888745
[TBL] [Abstract][Full Text] [Related]
4. Serum biomarkers in head and neck squamous cell cancer.
Kaskas NM; Moore-Medlin T; McClure GB; Ekshyyan O; Vanchiere JA; Nathan CA
JAMA Otolaryngol Head Neck Surg; 2014 Jan; 140(1):5-11. PubMed ID: 24232368
[TBL] [Abstract][Full Text] [Related]
5. Investigation of interleukin 10, 12 and 18 levels in patients with head and neck cancer.
Jebreel A; Mistry D; Loke D; Dunn G; Hough V; Oliver K; Stafford N; Greenman J
J Laryngol Otol; 2007 Mar; 121(3):246-52. PubMed ID: 17040593
[TBL] [Abstract][Full Text] [Related]
6. Plasma tumor necrosis factor-α and C-reactive protein as biomarker for survival in head and neck squamous cell carcinoma.
Andersson BÅ; Lewin F; Lundgren J; Nilsson M; Rutqvist LE; Löfgren S; Laytragoon-Lewin N
J Cancer Res Clin Oncol; 2014 Mar; 140(3):515-9. PubMed ID: 24481866
[TBL] [Abstract][Full Text] [Related]
7. In vitro cytokine release profile: predictive value for metastatic potential in head and neck squamous cell carcinomas.
Shkeir O; Athanassiou-Papaefthymiou M; Lapadatescu M; Papagerakis P; Czerwinski MJ; Bradford CR; Carey TE; Prince ME; Wolf GT; Papagerakis S
Head Neck; 2013 Nov; 35(11):1542-50. PubMed ID: 23322448
[TBL] [Abstract][Full Text] [Related]
8. Serum interleukin-12 and interleukin-18 levels in patients with oesophageal squamous cell carcinoma.
Diakowska D; Markocka-Maczka K; Grabowski K; Lewandowski A
Exp Oncol; 2006 Dec; 28(4):319-22. PubMed ID: 17285118
[TBL] [Abstract][Full Text] [Related]
9. Expression of the extracellular sulfatase SULF2 is associated with squamous cell carcinoma of the head and neck.
Flowers SA; Zhou X; Wu J; Wang Y; Makambi K; Kallakury BV; Singer MS; Rosen SD; Davidson B; Goldman R
Oncotarget; 2016 Jul; 7(28):43177-43187. PubMed ID: 27223083
[TBL] [Abstract][Full Text] [Related]
10. [Cytokine expression of transforming growth factor-beta2 and interleukin-10 in squamous cell carcinomas of the head and neck. Comparison of tissue expression and serum levels].
Karcher J; Reisser C; Daniel V; Herold-Mende C
HNO; 1999 Oct; 47(10):879-84. PubMed ID: 10550371
[TBL] [Abstract][Full Text] [Related]
11. Elevated serum levels of M30 and M65 in patients with locally advanced head and neck tumors.
Ozturk B; Coskun U; Sancak B; Yaman E; Buyukberber S; Benekli M
Int Immunopharmacol; 2009 May; 9(5):645-8. PubMed ID: 19249390
[TBL] [Abstract][Full Text] [Related]
12. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer.
Chen Z; Malhotra PS; Thomas GR; Ondrey FG; Duffey DC; Smith CW; Enamorado I; Yeh NT; Kroog GS; Rudy S; McCullagh L; Mousa S; Quezado M; Herscher LL; Van Waes C
Clin Cancer Res; 1999 Jun; 5(6):1369-79. PubMed ID: 10389921
[TBL] [Abstract][Full Text] [Related]
13. Interleukins 2 and 12 activate natural killer cytolytic responses of peripheral blood mononuclear cells from patients with head and neck squamous cell carcinoma.
Rashleigh SP; Kusher DI; Endicott JN; Rossi AR; Djeu JY
Arch Otolaryngol Head Neck Surg; 1996 May; 122(5):541-7. PubMed ID: 8615973
[TBL] [Abstract][Full Text] [Related]
14. Diet and proinflammatory cytokine levels in head and neck squamous cell carcinoma.
Arthur AE; Peterson KE; Shen J; Djuric Z; Taylor JM; Hebert JR; Duffy SA; Peterson LA; Bellile EL; Whitfield JR; Chepeha DB; Schipper MJ; Wolf GT; Rozek LS
Cancer; 2014 Sep; 120(17):2704-12. PubMed ID: 24830761
[TBL] [Abstract][Full Text] [Related]
15. Serum Levels of IGF-1 and IGFBP-3 in Relation to Clinical and Pathobiological Aspects of Head and Neck Squamous Cell Carcinomas.
Kalfert D; Ludvikova M; Topolcan O; Celakovsky P; Kucera R; Windrichova J; Ludvik J; Skalova K; Kulda V; Pesta M; Plzak J
Anticancer Res; 2017 Jun; 37(6):3281-3286. PubMed ID: 28551677
[TBL] [Abstract][Full Text] [Related]
16. Incomplete Th2 skewing of cytokines in plasma of patients with squamous cell carcinoma of the head and neck.
Lathers DM; Achille NJ; Young MR
Hum Immunol; 2003 Dec; 64(12):1160-6. PubMed ID: 14630398
[TBL] [Abstract][Full Text] [Related]
17. Macrophage colony-stimulating factor as a tumor marker for squamous cell carcinoma of the head and neck.
Kuropkat C; Dünne AA; Plehn S; Ossendorf M; Herz U; Renz H; Werner JA
Tumour Biol; 2003; 24(5):236-40. PubMed ID: 15001836
[TBL] [Abstract][Full Text] [Related]
18. Correlation of serum lactate dehydrogenase and alkaline phosphatase in different histological grades of head and neck squamous cell carcinoma and premalignant lesions.
Bhattacharjee A; Giri S; Roy M; Chakraborty A
J Cancer Res Ther; 2018; 14(5):934-940. PubMed ID: 30197328
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation in immune functions is reflected in tumor cell cytotoxicity by peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients.
Bose A; Chakraborty T; Chakraborty K; Pal S; Baral R
Cancer Immun; 2008 Jun; 8():10. PubMed ID: 18547033
[TBL] [Abstract][Full Text] [Related]
20. Modulation of Th1 and Th2 cytokine profiles and their association with advanced head and neck squamous cell carcinoma.
Sparano A; Lathers DM; Achille N; Petruzzelli GJ; Young MR
Otolaryngol Head Neck Surg; 2004 Nov; 131(5):573-6. PubMed ID: 15523428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
